Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Nam M Ho, MD
Family Practice · BROOKLYN PARK, MN · NPI 1235258690
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 592 | 177 |
| Amlodipine Besylate | Amlodipine Besylate | 443 | 133 |
| Losartan Potassium | Losartan Potassium | 346 | 107 |
| Lisinopril | Lisinopril | 338 | 101 |
| Omeprazole | Omeprazole | 246 | 67 |
| Metformin Hcl | Metformin Hcl | 234 | 74 |
| Metformin Hcl Er | Metformin Hcl | 226 | 64 |
| Simvastatin | Simvastatin | 216 | 61 |
| Gabapentin | Gabapentin | 205 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 199 | 59 |
| Tamsulosin Hcl | Tamsulosin Hcl | 167 | 52 |
| Levothyroxine Sodium | Levothyroxine Sodium | 158 | 41 |
| Glipizide Er | Glipizide | 155 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 151 | 55 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 128 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 124 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 122 | 40 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 115 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 112 | 47 |
| Jardiance | Empagliflozin | 104 | 31 |
| Carvedilol | Carvedilol | 97 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 94 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 91 | 22 |
| Famotidine | Famotidine | 86 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 85 | 22 |
| Alendronate Sodium | Alendronate Sodium | 84 | 26 |
| Allopurinol | Allopurinol | 83 | 24 |
| Furosemide | Furosemide | 82 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 81 | 26 |
| Meloxicam | Meloxicam | 72 | 22 |
| Tramadol Hcl | Tramadol Hcl | 72 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 70 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 69 | 23 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 66 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 65 | suppressed |
| Spironolactone | Spironolactone | 64 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 61 | 22 |
| Pregabalin | Pregabalin | 60 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 57 | 17 |
| Warfarin Sodium | Warfarin Sodium | 57 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 53 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 52 | 17 |
| Sertraline Hcl | Sertraline Hcl | 52 | 14 |
| Glimepiride | Glimepiride | 51 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 51 | 24 |
| Levetiracetam | Levetiracetam | 50 | suppressed |
| Eliquis | Apixaban | 49 | 18 |
| Methocarbamol | Methocarbamol | 49 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 49 | 14 |
| Potassium Chloride | Potassium Chloride | 49 | 14 |
| Prednisone | Prednisone | 49 | 23 |
| Ozempic | Semaglutide | 47 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 46 | 17 |
| Clonazepam | Clonazepam | 45 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 43 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 41 | 11 |
| Ibuprofen | Ibuprofen | 41 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 38 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 37 | 11 |
| Lovastatin | Lovastatin | 36 | suppressed |
| Atenolol | Atenolol | 35 | suppressed |
| Mounjaro | Tirzepatide | 33 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | suppressed |
| Tradjenta | Linagliptin | 31 | suppressed |
| Alprazolam | Alprazolam | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | 14 |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 26 | suppressed |
| Finasteride | Finasteride | 26 | 11 |
| Mirtazapine | Mirtazapine | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | 13 |
| Azelastine Hcl | Azelastine Hcl | 24 | suppressed |
| Ezetimibe | Ezetimibe | 24 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 24 | suppressed |
| Baclofen | Baclofen | 23 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 23 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Bumetanide | Bumetanide | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Oxycontin | Oxycodone Hcl | 17 | suppressed |
| Acarbose | Acarbose | 16 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 16 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Eletriptan Hbr | Eletriptan Hydrobromide | 11 | suppressed |
| Nabumetone | Nabumetone | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error